The Biden administration announced Wednesday that it supports waiving intellectual property protections for Covid-19 vaccines. Such a waiver could remove obstacles to ramping up the production of vaccines in developing countries. The move comes as coronavirus infections surge to their highest levels in countries that have struggled to procure or distribute vaccines.
COVID-19:
U.S. backs waiving patent protections for COVID vaccines, citing global health crisis
By CNBC
| May 05, 2021
Most Popular
#1
'COVID arm' rash seen after Moderna vaccine annoying but harmless, doctors say
An angry red rash being called “COVID arm” is a harmless but annoying response in some people who get the Moderna vaccine. Aside from sometimes being itchy, it doesn't appear to be dangerous, and...
Read More #2
CDC Announces New ICD-10-CM Codes for COVID-19-related Conditions
All six new codes will be effective January 1, 2021. ...
Read More #3
23 die in Norway after receiving Pfizer COVID-19 vaccine: officials
Twenty-three people died in Norway within days of receiving their first dose of the Pfizer COVID-19 vaccine, with 13 of those deaths — all nursing home patients — apparently related to the side...
Read More #4
Patients With Chronic Pain Feel Caught In An Opioid-Prescribing Debate
Faced with skyrocketing drug overdoses, states are cracking down on opioid prescribing. Some patients with chronic pain say they are becoming collateral damage. ...
Read More #5
New Online Calculator Estimates COVID-19 Mortality Risk
Individuals can use the online calculator to estimate their risk of dying from COVID-19 if they become infected with the coronavirus. ...
Read More